STOCK PURCHASE AGREEMENT By and Between JOHNSON & JOHNSON INNOVATION-JJDC, INC. AND ACHILLION PHARMACEUTICALS, INC. Dated as of May 19, 2015Stock Purchase Agreement • August 10th, 2015 • Achillion Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS STOCK PURCHASE AGREEMENT (this “Agreement”), dated as of May 19, 2015, by and between Johnson & Johnson Innovation-JJDC, Inc. (the “Investor”), a New Jersey corporation with its principal place of business at 410 George Street, New Brunswick, New Jersey 08901, and Achillion Pharmaceuticals, Inc. (the “Company”), a Delaware corporation, with its principal place of business at 300 George Street, New Haven, CT 06511.
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • August 10th, 2015 • Achillion Pharmaceuticals Inc • Pharmaceutical preparations • New York
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. INVESTOR AGREEMENT By and Between JOHNSON & JOHNSON INNOVATION-JJDC, INC. AND ACHILLION PHARMACEUTICALS, INC. Dated as...Investor Agreement • August 10th, 2015 • Achillion Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS INVESTOR AGREEMENT (this “Agreement”) is made as of , 2015, by and among Johnson & Johnson Innovation-JJDC, Inc., a New Jersey corporation with its principal place of business at 410 George Street, New Brunswick, New Jersey 08901 (“Investor”) and Achillion Pharmaceuticals, Inc. (the “Company”), a Delaware corporation with its principal place of business at 300 George Street, New Haven, CT 06511.
